Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/1/2000
 
First Published:
6/1/1999
1.
Phase II Study of 4'-Iodo-4'-Deoxydoxorubicin in Patients with Primary Systemic Amyloidosis (Summary Last Modified 09/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
MAYO-988003
NCI-T98-0003, NCT00003853, T98-0003
Last Modified:
4/1/1990
2.
Phase II Trial of 4'-Iodo-4'-deoxydoxorubicin in Patients with Advanced Breast Cancer (Summary Last Modified 04/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18 to 75
EORTC-16892B
Last Modified:
1/1/1991
3.
Phase II Trial of 4'-Iodo-4'-deoxydoxorubicin in Patients with Advanced Colorectal Adenocarcinoma (Summary Last Modified 01/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18 to 75
EORTC-16892C
Last Modified:
1/1/1991
4.
Phase II Trial of 4'-Iodo-4'-deoxydoxorubicin in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 01/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18 to 75
EORTC-16892N
Last Modified:
1/1/1991
5.
Phase II Trial of 4'-Iodo-4'-deoxydoxorubicin in Patients with Extensive Stage Small Cell Lung Cancer (Summary Last Modified 01/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18 to 75
EORTC-16892S
Last Modified:
1/31/2003
 
First Published:
2/1/2002
6.
Phase I Study of Iododoxorubicin in Patients With Primary Systemic Amyloidosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
MAYO-MC0113
NCI-5718, NCT00030381, 5718
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute